BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 19627112)

  • 21. Mapping the surface of Escherichia coli peptide deformylase by NMR with organic solvents.
    Byerly DW; McElroy CA; Foster MP
    Protein Sci; 2002 Jul; 11(7):1850-3. PubMed ID: 12070337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A peptide deformylase-ribosome complex reveals mechanism of nascent chain processing.
    Bingel-Erlenmeyer R; Kohler R; Kramer G; Sandikci A; Antolić S; Maier T; Schaffitzel C; Wiedmann B; Bukau B; Ban N
    Nature; 2008 Mar; 452(7183):108-11. PubMed ID: 18288106
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hydroxamic acids as potent inhibitors of Fe(II) and Mn(II) E. coli methionine aminopeptidase: biological activities and X-ray structures of oxazole hydroxamate-EcMetAP-Mn complexes.
    Huguet F; Melet A; Alves de Sousa R; Lieutaud A; Chevalier J; Maigre L; Deschamps P; Tomas A; Leulliot N; Pages JM; Artaud I
    ChemMedChem; 2012 Jun; 7(6):1020-30. PubMed ID: 22489069
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structures of E. coli peptide deformylase bound to formate: insight into the preference for Fe2+ over Zn2+ as the active site metal.
    Jain R; Hao B; Liu RP; Chan MK
    J Am Chem Soc; 2005 Apr; 127(13):4558-9. PubMed ID: 15796505
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and antibacterial activity of peptide deformylase inhibitors.
    Huntington KM; Yi T; Wei Y; Pei D
    Biochemistry; 2000 Apr; 39(15):4543-51. PubMed ID: 10758004
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of peptide deformylase2 from B. cereus.
    Park JK; Kim KH; Moon JH; Kim EE
    J Biochem Mol Biol; 2007 Nov; 40(6):1050-7. PubMed ID: 18047803
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peptide deformylase inhibitors with non-peptide scaffold: synthesis and structure-activity relationships.
    Lee SK; Choi KH; Lee SJ; Lee JS; Park JY; Kim BM; Lee BJ
    Bioorg Med Chem Lett; 2011 Jan; 21(1):133-6. PubMed ID: 21146987
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural Insights into Antibacterial Payload Release from Gold Nanoparticles Bound to E. coli Peptide Deformylase.
    Kirschner H; John M; Zhou T; Bachmann N; Schultz A; Hofmann E; Bandow JE; Scherkenbeck J; Metzler-Nolte N; Stoll R
    ChemMedChem; 2024 Mar; 19(6):e202300538. PubMed ID: 38057137
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trapping conformational states along ligand-binding dynamics of peptide deformylase: the impact of induced fit on enzyme catalysis.
    Fieulaine S; Boularot A; Artaud I; Desmadril M; Dardel F; Meinnel T; Giglione C
    PLoS Biol; 2011 May; 9(5):e1001066. PubMed ID: 21629676
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 2-(2-Oxo-1,4-dihydro-2H-quinazolin-3-yl)- and 2-(2,2-dioxo-1,4-dihydro-2H-2lambda6-benzo[1,2,6]thiadiazin-3-yl)-N-hydroxy-acetamides as potent and selective peptide deformylase inhibitors.
    Apfel C; Banner DW; Bur D; Dietz M; Hubschwerlen C; Locher H; Marlin F; Masciadri R; Pirson W; Stalder H
    J Med Chem; 2001 Jun; 44(12):1847-52. PubMed ID: 11384231
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure-activity relationships of the peptide deformylase inhibitor BB-3497: modification of the metal binding group.
    Smith HK; Beckett RP; Clements JM; Doel S; East SP; Launchbury SB; Pratt LM; Spavold ZM; Thomas W; Todd RS; Whittaker M
    Bioorg Med Chem Lett; 2002 Dec; 12(24):3595-9. PubMed ID: 12443784
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Binding affinities and geometries of various metal ligands in peptide deformylase inhibitors.
    Madison V; Duca J; Bennett F; Bohanon S; Cooper A; Chu M; Desai J; Girijavallabhan V; Hare R; Hruza A; Hendrata S; Huang Y; Kravec C; Malcolm B; McCormick J; Miesel L; Ramanathan L; Reichert P; Saksena A; Wang J; Weber PC; Zhu H; Fischmann T
    Biophys Chem; 2002 Dec; 101-102():239-47. PubMed ID: 12488004
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanism of time-dependent inhibition of polypeptide deformylase by actinonin.
    Van Aller GS; Nandigama R; Petit CM; DeWolf WE; Quinn CJ; Aubart KM; Zalacain M; Christensen SB; Copeland RA; Lai Z
    Biochemistry; 2005 Jan; 44(1):253-60. PubMed ID: 15628866
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural basis for the inhibition of M1 family aminopeptidases by the natural product actinonin: Crystal structure in complex with E. coli aminopeptidase N.
    Ganji RJ; Reddi R; Gumpena R; Marapaka AK; Arya T; Sankoju P; Bhukya S; Addlagatta A
    Protein Sci; 2015 May; 24(5):823-31. PubMed ID: 25644575
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Asymmetric synthesis of BB-3497--a potent peptide deformylase inhibitor.
    Pratt LM; Beckett RP; Davies SJ; Launchbury SB; Miller A; Spavold ZM; Todd RS; Whittaker M
    Bioorg Med Chem Lett; 2001 Oct; 11(19):2585-8. PubMed ID: 11551755
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular cloning and characterization of a new peptide deformylase from human pathogenic bacterium Helicobacter pylori.
    Han C; Wang Q; Dong L; Sun H; Peng S; Chen J; Yang Y; Yue J; Shen X; Jiang H
    Biochem Biophys Res Commun; 2004 Jul; 319(4):1292-8. PubMed ID: 15194508
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structure and mechanism of Escherichia coli glutathionylspermidine amidase belonging to the family of cysteine; histidine-dependent amidohydrolases/peptidases.
    Pai CH; Wu HJ; Lin CH; Wang AH
    Protein Sci; 2011 Mar; 20(3):557-66. PubMed ID: 21226054
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of novel potent hydroxamic acid inhibitors of peptidyl deformylase and the importance of the hydroxamic acid functionality on inhibition.
    Thorarensen A; Deibel MR; Rohrer DC; Vosters AF; Yem AW; Marshall VD; Lynn JC; Bohanon MJ; Tomich PK; Zurenko GE; Sweeney MT; Jensen RM; Nielsen JW; Seest EP; Dolak LA
    Bioorg Med Chem Lett; 2001 Jun; 11(11):1355-8. PubMed ID: 11378353
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design, Synthesis, and Biological Evaluation of Vanillin Hydroxamic Acid Derivatives as Novel Peptide Deformylase Inhibitors.
    Gao J; Qiu S; Liang L; Hao Z; Zhou Q; Wang F; Mou J; Lin Q
    Curr Comput Aided Drug Des; 2018; 14(1):95-101. PubMed ID: 28606047
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bacterial Peptide deformylase inhibitors: a new class of antibacterial agents.
    Jain R; Chen D; White RJ; Patel DV; Yuan Z
    Curr Med Chem; 2005; 12(14):1607-21. PubMed ID: 16022661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.